Patents by Inventor Anthony S. Drager

Anthony S. Drager has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL PRODRUGS AND METHODS OF THEIR PREPARATION AND USE
    Publication number: 20210361777
    Abstract: The disclosure provides compounds of Formula (I), wherein X, Y, and Z are defined herein. The disclosure also provides particles comprising one or more compounds described herein, compositions comprising one or more compounds or particles described herein and a pharmaceutically acceptable carrier, and methods of treating a subject in need thereof comprising administering one or more compounds, particles, or compositions described herein to the subject.
    Type: Application
    Filed: July 23, 2021
    Publication date: November 25, 2021
    Inventors: Anthony S. DRAGER, Paritosh WATTAMWAR
  • Pharmaceutical prodrugs and methods of their preparation and use
    Patent number: 11071789
    Abstract: The disclosure provides compounds of Formula (I), wherein X, Y, and Z are defined herein. The disclosure also provides particles comprising one or more compounds described herein, compositions comprising one or more compounds or particles described herein and a pharmaceutically acceptable carrier, and methods of treating a subject in need thereof comprising administering one or more compounds, particles, or compositions described herein to the subject. X—Y—Z??(I).
    Type: Grant
    Filed: July 13, 2017
    Date of Patent: July 27, 2021
    Assignee: Cephalon, Inc.
    Inventors: Anthony S. Drager, Paritosh Wattamwar
  • LIQUID FORMULATIONS OF BENDAMUSTINE
    Publication number: 20210113530
    Abstract: Stable liquid formulations of bendamustine, and pharmaceutically acceptable salts thereof, and polar aprotic solvents, are described.
    Type: Application
    Filed: September 9, 2020
    Publication date: April 22, 2021
    Inventors: Anthony S. Drager, Rachel Y. LaBell, Piyush R. Patel
  • LIQUID FORMULATIONS OF BENDAMUSTINE
    Publication number: 20210008035
    Abstract: Stable liquid formulations of bendamustine, and pharmaceutically acceptable salts thereof, and polar aprotic solvents, are described.
    Type: Application
    Filed: March 31, 2020
    Publication date: January 14, 2021
    Inventors: Anthony S. Drager, Rachel Y. LaBell, Piyush R. Patel
  • PHARMACEUTICAL PRODRUGS AND METHODS OF THEIR PREPARATION AND USE
    Publication number: 20190240348
    Abstract: The disclosure provides compounds of Formula (I), wherein X, Y, and Z are defined herein. The disclosure also provides particles comprising one or more compounds described herein, compositions comprising one or more compounds or particles described herein and a pharmaceutically acceptable carrier, and methods of treating a subject in need thereof comprising administering one or more compounds, particles, or compositions described herein to the subject. X—Y—Z??(I).
    Type: Application
    Filed: July 13, 2017
    Publication date: August 8, 2019
    Applicant: Cephalon, Inc.
    Inventors: Anthony S. DRAGER, Paritosh WATTAMWAR
  • Nanoparticulate and macroparticulate formulations
    Patent number: 10201506
    Abstract: The present invention is directed to particles prepared via the polymerization of at least one surfactant and an isocyanate-containing compound. Pharmaceutical compositions prepared using these particles are also described.
    Type: Grant
    Filed: February 6, 2017
    Date of Patent: February 12, 2019
    Assignee: CEPHALON, INC.
    Inventors: Peter D. Brown, Anthony S. Drager
  • BENDAMUSTINE DERIVATIVES AND METHODS OF USING SAME
    Publication number: 20180147186
    Abstract: The present invention is directed to bendamustine esters and bendamustine amides and their use for the treatment of cancer.
    Type: Application
    Filed: January 24, 2018
    Publication date: May 31, 2018
    Applicant: IGNYTA, INC.
    Inventors: Roger P. BAKALE, Peter D. BROWN, Jian CHEN, Anthony S. DRAGER, Rachel Y. LABELL, Robert E. MCKEAN, Piyush R. PATEL, Renee C. ROEMMELE
  • LIQUID FORMULATIONS OF BENDAMUSTINE
    Publication number: 20180125824
    Abstract: Stable liquid formulations of bendamustine, and pharmaceutically acceptable salts thereof, and polar aprotic solvents, are described.
    Type: Application
    Filed: August 28, 2017
    Publication date: May 10, 2018
    Inventors: Anthony S. Drager, Rachel Y. LaBell, Piyush R. Patel
  • Bendamustine derivatives and methods of using same
    Patent number: 9913827
    Abstract: The present invention is directed to bendamustine esters and bendamustine amides and their use for the treatment of cancer.
    Type: Grant
    Filed: March 10, 2017
    Date of Patent: March 13, 2018
    Assignee: IGNYTA, INC.
    Inventors: Roger P. Bakale, Peter D. Brown, Jian Chen, Anthony S. Drager, Rachel Y. LaBell, Robert E. McKean, Piyush R. Patel, Renee C. Roemmele
  • BENDAMUSTINE DERIVATIVES AND METHODS OF USING SAME
    Publication number: 20170182008
    Abstract: The present invention is directed to bendamustine esters and bendamustine amides and their use for the treatment of cancer.
    Type: Application
    Filed: March 10, 2017
    Publication date: June 29, 2017
    Applicant: IGNYTA, INC.
    Inventors: Roger P. Bakale, Peter D. Brown, Jian Chen, Anthony S. Drager, Rachel Y. LaBell, Robert E. McKean, Piyush R. Patel, Renee C. Roemmele
  • NANOPARTICULATE AND MACROPARTICULATE FORMULATIONS
    Publication number: 20170143640
    Abstract: The present invention is directed to particles prepared via the polymerization of at least one surfactant and an isocyanate-containing compound. Pharmaceutical compositions prepared using these particles are also described.
    Type: Application
    Filed: February 6, 2017
    Publication date: May 25, 2017
    Inventors: Peter D. Brown, Anthony S. Drager
  • Bendamustine derivatives and methods of using same
    Patent number: 9630926
    Abstract: The present invention is directed to bendamustine esters and bendamustine amides and their use for the treatment of cancer.
    Type: Grant
    Filed: June 16, 2016
    Date of Patent: April 25, 2017
    Assignee: IGNYTA, INC.
    Inventors: Roger P. Bakale, Peter D. Brown, Jian Chen, Anthony S. Drager, Rachel Y. LaBell, Robert E. McKean, Piyush R. Patel, Renee C. Roemmele
  • Nanoparticulate and macroparticulate formulations
    Patent number: 9598377
    Abstract: The present invention is directed to particles prepared via the polymerization of at least one surfactant and an isocyanate-containing compound. Pharmaceutical compositions prepared using these particles are also described.
    Type: Grant
    Filed: March 12, 2014
    Date of Patent: March 21, 2017
    Assignee: Cephalon, Inc.
    Inventors: Peter D. Brown, Anthony S. Drager
  • BENDAMUSTINE DERIVATIVES AND METHODS OF USING SAME
    Publication number: 20160289198
    Abstract: The present invention is directed to bendamustine esters and bendamustine amides and their use for the treatment of cancer.
    Type: Application
    Filed: June 16, 2016
    Publication date: October 6, 2016
    Applicant: Ignyta, Inc.
    Inventors: Roger P. BAKALE, Peter D. BROWN, Jian CHEN, Anthony S. DRAGER, Rachel Y. LABELL, Robert E. MCKEAN, Piyush R. PATEL, Renee C. ROEMMELE
  • Bendamustine derivatives and methods of using same
    Patent number: 9452988
    Abstract: The present invention is directed to bendamustine esters and bendamustine amides and their use for the treatment of cancer.
    Type: Grant
    Filed: November 12, 2013
    Date of Patent: September 27, 2016
    Assignee: Ignyta, Inc.
    Inventors: Roger P. Bakale, Peter D. Brown, Jian Chen, Anthony S. Drager, Rachel Y. Labell, Robert E. McKean, Piyush R. Patel, Renee C. Roemmele, Bradley McIntyre
  • BENDAMUSTINE DERIVATIVES AND METHODS OF USING SAME
    Publication number: 20160016912
    Abstract: The present invention is directed to bendamustine esters and bendamustine amides and their use for the treatment of cancer.
    Type: Application
    Filed: September 28, 2015
    Publication date: January 21, 2016
    Inventors: Roger P. BAKALE, Peter D. BROWN, Jian CHEN, Anthony S. DRAGER, Rachel Y. LABELL, Robert E. MCKEAN, Piyush R. PATEL, Renee C. ROEMMELE
  • NANOPARTICULATE AND MACROPARTICULATE FORMULATIONS
    Publication number: 20160002173
    Abstract: The present invention is directed to particles prepared via the polymerization of at least one surfactant and an isocyanate-containing compound. Pharmaceutical compositions prepared using these particles are also described.
    Type: Application
    Filed: March 12, 2014
    Publication date: January 7, 2016
    Inventors: Peter D. BROWN, Anthony S. DRAGER
  • Liquid Formulations of Bendamustine
    Publication number: 20150335750
    Abstract: Stable liquid formulations of bendamustine, and pharmaceutically acceptable salts thereof, and polar aprotic solvents, are described.
    Type: Application
    Filed: July 31, 2015
    Publication date: November 26, 2015
    Inventors: Anthony S. Drager, Rachel Y. LaBell, Piyush R. Patel
  • Bendamustine derivatives and methods of using same
    Patent number: 9149464
    Abstract: The present invention is directed to bendamustine esters and bendamustine amides and their use for the treatment of cancer.
    Type: Grant
    Filed: May 13, 2015
    Date of Patent: October 6, 2015
    Assignee: IGNYTA, INC.
    Inventors: Roger P. Bakale, Peter D. Brown, Jian Chen, Anthony S. Drager, Rachel Y. Labell, Robert E. McKean, Piyush R. Patel, Renee C. Roemmele
  • Bendamustine derivatives and methods of using same
    Patent number: 9150517
    Abstract: The present invention is directed to bendamustine esters and bendamustine amides and their use for the treatment of cancer.
    Type: Grant
    Filed: April 29, 2015
    Date of Patent: October 6, 2015
    Assignee: IGNYTA, INC.
    Inventors: Roger P. Bakale, Peter D. Brown, Jian Chen, Anthony S. Drager, Rachel Y. Labell, Robert E. McKean, Piyush R. Patel, Renee C. Roemmele